1
|
Dong Y, Kong LQ, Chen QH, Li B, Zeng XH, Ke LN, Wang HM. Green synthesis, crystal structure, and antifungal activities of (E)-4-arylidene-5-oxotetrahydrofuran. Front Chem 2022; 10:997095. [PMID: 36157041 PMCID: PMC9500531 DOI: 10.3389/fchem.2022.997095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Accepted: 08/23/2022] [Indexed: 11/13/2022] Open
Abstract
A series of γ-lactone derivatives (E)-4-arylidene-5-oxotetrahydrofuran derivatives were synthesized via a tandem Passerini 3CC/SN cyclization microwave-assisted one-pot method efficiently starting from Baylis Hillman acids, aryl glyoxals and isocyanides, and using ionic liquid as reaction medium. The products were characterized by hydrogen nuclear magnetic resonance spectroscopy (1H-NMR), carbon nuclear magnetic resonance spectroscopy (13C-NMR). Single crystal X-ray analysis of the compound RPDFB clearly confirmed its assigned chemical structures. Meanwhile, the effects of four compounds (RPDFB, RPDFC, RPDFI, RPDFJ) on the growth inhibition activity of Gibberella zeae were detected, and found that the compound RPDFB has significant growth inhibition activity to Gibberella zeae.
Collapse
Affiliation(s)
- Yun Dong
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
| | - Ling-Qi Kong
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
| | - Qin-Hua Chen
- Shenzhen Baoan Authentic TCM Therapy Hospital, Shenzhen, China
| | - Bin Li
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
| | - Xiao-Hua Zeng
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
- *Correspondence: Xiao-Hua Zeng, ; Li-Na Ke, ; Hong-Mei Wang,
| | - Li-Na Ke
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
- *Correspondence: Xiao-Hua Zeng, ; Li-Na Ke, ; Hong-Mei Wang,
| | - Hong-Mei Wang
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
- *Correspondence: Xiao-Hua Zeng, ; Li-Na Ke, ; Hong-Mei Wang,
| |
Collapse
|
2
|
Ke LN, Kong LQ, Zhu XL, Wu FX, Chen QH, Li B, Dong Y, Wang HM, Zeng XH. Green synthesis, structure optimization and biological evalution of Rhopaladins’ analog 2–styryl–5-oxopyrrolidine-2- carboxamide RPDPRH on CaSki cells. Front Chem 2022; 10:975559. [PMID: 36110131 PMCID: PMC9468594 DOI: 10.3389/fchem.2022.975559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2022] [Accepted: 07/29/2022] [Indexed: 12/24/2022] Open
Abstract
We have synthesized Rhopaladins’ analog (2E,4E)-4-chlorobenzylidene-2-(4-chlorostyryl)-N-cyclohexyl-1-(4-fluorophenyl)-5-oxopyrrolidine-2-carboxamide (RPDPRH) via a highly facile, inexpensive and green approach and verified the structural superiority of compound RPDPRH through molecular docking. Moreover, we further detected the anti-proliferation, apoptosis and HPV E6/E7 effects of RPDPRH on CaSki cells. Finally, we confirmed that compared with the previous compound (E)-N-(tert-butyl)-2-(4-chlorobenzoyl)-4-(4-fluorobenzylidene)-1-isopropyl-5-oxopyrrolidine-2-carboxamide (RPDPB), RPDPRH could better inhibit proliferation, induce apoptosis, and down-regulate HPV E6/E7 mRNA expression on Caski cells. And preliminary RT-PCR experiments have demonstrated that RPDPRH also could affect the expression of Bcl-2, Bax and Caspase-3 mRNA in Caski cells. In summary, RPDPRH has potential as an effective agent against cervical cancer and will play an important role in our subsequent research.
Collapse
Affiliation(s)
- Li-Na Ke
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
| | - Ling-Qi Kong
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
| | - Xiu-Lian Zhu
- Animal Laboratory, The 924th Hospital of the Joint Logistics Support Force of Chinese PLA, Guilin, China
| | - Feng-Xu Wu
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
| | - Qin-Hua Chen
- Shenzhen Baoan Authentic TCM Therapy Hospital, Shenzhen, China
| | - Bin Li
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
| | - Yun Dong
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
- *Correspondence: Yun Dong, ; Hong-Mei Wang, ; Xiao-Hua Zeng,
| | - Hong-Mei Wang
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
- *Correspondence: Yun Dong, ; Hong-Mei Wang, ; Xiao-Hua Zeng,
| | - Xiao-Hua Zeng
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, China
- *Correspondence: Yun Dong, ; Hong-Mei Wang, ; Xiao-Hua Zeng,
| |
Collapse
|
3
|
Zhu J, Kong LQ, Chen QH, Li B, Wu L, Ran FY, Ke LN, Zeng XH, Wang HM. Design, Synthesis, and Apoptosis-Promoting Effect Evaluation of Rhopaladins’ Analog 4-Arylidene-5-Oxopyrrolidine Derivatives. Front Chem 2022; 10:898436. [PMID: 35665067 PMCID: PMC9157788 DOI: 10.3389/fchem.2022.898436] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Accepted: 04/11/2022] [Indexed: 11/18/2022] Open
Abstract
Marine alkaloids have novel structures and antitumor activities. Therefore, we synthesized rhopaladins’ analogs from marine alkaloids rhopaladins A-D and modified their structures to synthesize 4-benzylidene-5-pyrrolidone derivatives. Among the compounds, (2E, 4E)-4-(4-chlorobenzylidene)-2-(4-chlorostyryl)-N-cyclohexyl-1-(4-fluorophenyl)-5-oxopyrrolidine-2-carboxamide (RPDPRH) has high efficiency and less hepatotoxicity, with IC50 values of 4.66, 6.42, 17.66, 15.2, 12.36, 22.4, and 243.2 μM in vitro anti-proliferative activity testing against cervical cancer C-33A, CaSki, SiHa, and HeLa cells, human hepatocarcinoma HepG2 and 7402 cells, and human normal liver LO2 cells, respectively. In particular, RPDPRH has similar activity to cisplatin on human hepatocarcinoma cells, and cisplatin served as a positive control in our study. Next, the apoptosis of HepG2 and 7402 cells induced by RPDPRH at different concentrations was detected by Annexin V/PI flow cytometry. Moreover, the expression of apoptotic proteins was detected by Western blot analysis. Finally, the results showed that RPDPRH could induce apoptosis of hepatocarcinoma cells by regulating Bax and Bcl-2 expressions. In summary, our results indicate that RPDPRH has the potential to serve as an antitumor agent and plays a significant role in future studies.
Collapse
Affiliation(s)
- Jun Zhu
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Hubei, China
| | - Ling-Qi Kong
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Hubei, China
| | - Qin-Hua Chen
- Shenzhen Baoan Authentic TCM Therapy Hospital, Shenzhen, China
| | - Bin Li
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
| | - Lun Wu
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
| | - Feng-Ying Ran
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
| | - Li-Na Ke
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- *Correspondence: Li-Na Ke, ; Xiao-Hua Zeng, ; Hong-Mei Wang,
| | - Xiao-Hua Zeng
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Hubei, China
- *Correspondence: Li-Na Ke, ; Xiao-Hua Zeng, ; Hong-Mei Wang,
| | - Hong-Mei Wang
- Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
- Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Hubei, China
- *Correspondence: Li-Na Ke, ; Xiao-Hua Zeng, ; Hong-Mei Wang,
| |
Collapse
|